论文部分内容阅读
目的观察中药灌肠联合特拉唑嗪治疗Ⅲ_ B型前列腺炎的临床疗效。方法90例Ⅲ_B型前列腺炎患者随机分成两组,对照组45例仅口服特拉唑嗪2mg,1次/d,治疗14d;治疗组在口服特拉唑嗪基础上给予中药保留灌肠,1次/d,治疗14d。结果对照组病例全部完成临床观察,治疗组有4例病例未完成临床观察,全部病例无不良事件发生。两组NIH-CPSI评分治疗后每个变量与治疗前比较差异均有统计学意义(P<0.05或P<0.01);治疗后治疗组NIH-CPSI评分与对照组相比具有统计学差异(P<0.05);两组NIH-CPSI评分治疗前后差值(d)相比,具有显著差异(P<0.05或P<0.01)。结论中药灌肠联合特拉唑嗪可显著提高Ⅲ_B型前列腺炎疗效。
Objective To observe the clinical efficacy of traditional Chinese medicine enema combined with terazosin in the treatment of type Ⅲ_ B prostatitis. Methods Ninety patients with type Ⅲ_B prostatitis were randomly divided into two groups. In the control group, only 45 cases were treated with terazosin 2 mg once daily for 14 days. The treatment group was given traditional Chinese medicine retention enema on the basis of oral terazosin once / d, treatment 14d. Results All the patients in the control group completed the clinical observation. In the treatment group, 4 cases did not complete the clinical observation, and no adverse events occurred in all the cases. The NIH-CPSI scores of two groups were significantly different from those before treatment (P <0.05 or P <0.01). After treatment, the NIH-CPSI score of the treatment group was significantly higher than that of the control group (P <0.05). There was significant difference (P <0.05 or P <0.01) between the NIH-CPSI scores before and after treatment (d). Conclusion Chinese medicine enema combined with terazosin can significantly improve the efficacy of type Ⅲ_B prostatitis.